The adoption of robotic technology in the treatment of prostate cancer (PCa) could lead to improvement in outcomes.
To evaluate feasibility, to compare functional outcomes, and to assess the economic benefits of removing catheter on the postoperative day (POD) 3 versus POD 5 after robot-assisted radical prostatectomy (RARP).